Huzaifa Ahmad Cheema, Karan Bhanushali, Aruba Sohail, Areej Fatima, Alaa Hamza Hermis, Anoop Titus, Adeel Ahmad, Vidit Majmundar, Wajeeh Ur Rehman, Samian Sulaiman, Vladimir Lakhter, Suzanne J Baron, Sourbha S Dani
A strategy of complete revascularization (CR) is recommended in patients with acute coronary syndrome (ACS) and multivessel disease (MVD). However, the optimal timing of CR remains equivocal. We searched MEDLINE, Embase, the Cochrane Library, and ClinicalTrials.gov for randomized controlled trials (RCTs) comparing immediate CR (ICR) with staged CR (SCR) in patients with ACS and MVD. Our primary outcomes were all-cause and cardiovascular mortality. All outcomes were assessed at three time points: in-hospital or at 30 days, at 6 months-1 year, and at > 1 year...
April 4, 2024: American Journal of Cardiology